PAI Pharma acquires Nexus Pharmaceuticals to expand medicines portfolio

US pharmaceutical company PAI Pharma has agreed to acquire Nexus Pharmaceuticals, adding specialist sterile injectable medicines to its existing product portfolio. The transaction will strengthen its position in hospital medicines and pharmaceutical manufacturing. HPC could identify pharmaceutical manufacturers, packaging suppliers, specialist distributors, contract manufacturing organisations and other healthcare businesses that may be suitable for acquisition or strategic partnerships.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.